Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients
Receptor Protein-Tyrosine Kinases
Relapses were most frequently patient-detected in all stage II substages, highlighting the importance of patient education and self-examination. The highest yield for routine imaging is in stage IIC patients during the first 4 years. Physician examination is unlikely to detect relapses beyond 3 years for stage IIA and IIB and beyond 2 years for stage IIC patients.